Clinical Trial Update: Ph2a Study to Evaluate IW-3718 in Patients With Gastroesophageal Reflux Not Completely Responsive to Proton Pump Inhibitors [Phase 2]

View source ↗

Summary

Phase 2a study evaluating IW-3718 in patients with gastroesophageal reflux disease not fully controlled by proton pump inhibitors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• IW-3718

Snippet

Sponsor: Ironwood Pharmaceuticals, Inc. | Conditions: Gastroesophageal Reflux | Phase 2 | Status: COMPLETED